Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

This study has been completed.
Sponsor:
Collaborator:
Grifols Therapeutics Inc.
Information provided by:
The Center for Rheumatic Disease, Allergy, & Immunology
ClinicalTrials.gov Identifier:
NCT00417573
First received: December 28, 2006
Last updated: December 29, 2006
Last verified: December 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given
No publications provided by The Center for Rheumatic Disease, Allergy, & Immunology

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):